Cytokinetics (CYTK) Earnings Date, Estimates & Call Transcripts $51.94 +1.72 (+3.42%) (As of 11/18/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cytokinetics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 25EstimatedActual EPS (Nov. 6) -$1.36 Missed By -$0.09 Consensus EPS (Nov. 6) -$1.27 Cytokinetics announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$1.36, which missed analysts' consensus estimates of -$1.27 by $0.09. Quarterly revenue rose 22.5% year-over-year to $0.46 million, below the consensus estimate of $1.21 million. With a trailing EPS of -$5.38, Cytokinetics' earnings are expected to decrease next year, from ($4.32) to ($5.28) per share. Conference Call TranscriptConference Call AudioCYTK Upcoming EarningsCytokinetics' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules. Get Cytokinetics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cytokinetics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCYTK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CYTK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceAmerica’s future explained in one mapA silent invasion is about to change everything. Will you be prepared?Click the map to find out what happens next Cytokinetics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$1.33-$0.89-$1.14Q2 20243-$1.16-$1.05-$1.10Q3 20243-$1.30-$1.18-$1.22Q4 20243-$1.60-$1.27-$1.41FY 202412($5.39)($4.39)($4.88) Cytokinetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/25/2025(Estimated)------- 11/6/2024Q3 2024-$1.27-$1.36 -$0.09-$1.36$1.21M$0.46M 8/8/2024Q2 2024-$1.06-$1.31 -$0.25-$1.31$7.61M$0.25M 5/8/2024Q1 2024-$1.16-$1.33 -$0.17-$1.33$0.91M$0.84M 2/27/2024Q4 2023-$1.03-$1.38 -$0.35-$1.38$7.62M$1.70M 11/2/2023Q3 2023-$0.72-$1.35 -$0.63-$1.35$24.71M$0.38M 8/3/2023Q2 2023-$1.23-$1.34 -$0.11-$1.34$5.67M$0.87M Get the Latest News and Ratings for CYTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytokinetics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$1.24-$1.38 -$0.14-$1.38$2.50M$4.60M 3/1/2023Q4 2022-$1.22-$1.45 -$0.23-$1.45$7.10M$1.96M Cytokinetics Earnings - Frequently Asked Questions When is Cytokinetics's earnings date? Cytokinetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on CYTK's earnings history. Did Cytokinetics beat their earnings estimates last quarter? In the previous quarter, Cytokinetics (NASDAQ:CYTK) missed the analysts' consensus estimate of ($1.27) by $0.09 with a reported earnings per share (EPS) of ($1.36). Learn more on analysts' earnings estimate vs. CYTK's actual earnings. How can I listen to Cytokinetics's earnings conference call? The conference call for Cytokinetics's latest earnings report can be listened to online. Listen to Conference Call How can I read Cytokinetics's conference call transcript? The conference call transcript for Cytokinetics's latest earnings report can be read online. Read Transcript How much revenue does Cytokinetics generate each year? Cytokinetics (NASDAQ:CYTK) has a recorded annual revenue of $7.53 million. How much profit does Cytokinetics generate each year? Cytokinetics (NASDAQ:CYTK) has a recorded net income of -$526.24 million. CYTK has generated -$5.38 earnings per share over the last four quarters. What is Cytokinetics's EPS forecast for next year? Cytokinetics's earnings are expected to decrease from ($4.32) per share to ($5.28) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies ORIC Earnings PHAT Earnings NKTX Earnings KPTI Earnings BTAI Earnings BNTX Earnings TEVA Earnings BGNE Earnings MRNA Earnings VTRS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report America’s future explained in one map (Ad)A silent invasion is about to change everything. Will you be prepared?Click the map to find out what happens next This page (NASDAQ:CYTK) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
